Securian Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
33,276
+41
+0.1% +$1.21K 0.04% 310
2026
Q1
$921K Buy
33,235
+1,303
+4% +$33.5K 0.04% 361
2025
Q4
$693K Sell
31,932
-216
-0.7% -$4.26K 0.03% 468
2025
Q3
$486K Buy
32,148
+174
+0.5% +$2.15K 0.01% 701
2025
Q2
$360K Hold
31,974
0.01% 802
2025
Q1
$323K Sell
31,974
-494
-2% -$5.34K 0.01% 823
2024
Q4
$384K Sell
32,468
-1,460
-4% -$17.3K 0.01% 786
2024
Q3
$392K Buy
33,928
+6,934
+26% +$78.9K 0.01% 791
2024
Q2
$285K Sell
26,994
-826
-3% -$9.05K 0.01% 848
2024
Q1
$293K Buy
+27,820
New +$300K 0.01% 851

Other funds holding ROIV

Securian Asset Management's ROIV Position: Q2 2026 in Review

Securian Asset Management increased its Roivant Sciences (ROIV) stake by 0.12% in Q2 2026, buying an estimated $1.21K and bringing the position to 33,276 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #310.

Securian Asset Management first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Securian Asset Management held 33,276 shares of Roivant Sciences worth $1.15M as of Q2 2026.
  • Securian Asset Management bought 41 Roivant Sciences shares in Q2 2026, an estimated $1.21K.
  • Roivant Sciences made up 0.04% of Securian Asset Management's portfolio in Q2 2026, its #310 holding.
  • Securian Asset Management first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.